Medline turned to Ranpak Holdings Corp. to eliminate a growing bottleneck at pack-out. The company now picks directly into a ...
Net sales of $7.4 billion, an increase of 10.7% Net income of $239 million, a decrease of 25.8% Adjusted EBITDA 1 of $776 million, a ...
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. With over $28 billion in revenue during 2025, Medline distributes more than 335,000 stock-keeping ...
Net sales of $7.4 billion, an increase of 10.7%Net income of $239 million, a decrease of 25.8%Adjusted EBITDA1 of $776 million, a decrease of 10.6%Raising full year 2026 Organic Sales2 guidance range ...
Medline rolls out predictive supply chain tool Mpower to help U.S. health systems improve order substitution workflows and manage disruptions.
On a per-share basis, the Northfield, Illinois-based company said it had profit of 16 cents. Earnings, adjusted for non-recurring costs, were 33 cents per share. The results surpassed Wall Street ...
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip ...
Investors can’t seem to get enough of artificial intelligence infrastructure stocks, and that is pointing to massive demand for semiconductor chip designer Cerebras’ upcoming IPO. Cerebras, which ...
Supply disruptions of neurosurgical patties, sponges and strip devices could affect patient care and neurosurgical procedures through the end of 2026, according to a May 6 letter by the FDA. The ...
Medline Inc. (NASDAQ:MDLN) is one of the best young stocks to buy and hold for the next decade. On May 4, Medline officially ...
May 6 (Reuters) - The U.S. Food and Drug Administration on Wednesday acknowledged ongoing supply disruptions of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results